Introduction
With the advent of potent immunosuppressive drugs for renal transplantation, the scope of potential living kidney donations to patients with endstage renal disease (ESRD) has widened. In most countries with transplant programmes, this practice has been confined to donors related, either genetically or in some cases emotionally, to the recipient. The transplant community has voiced concerns about this practice, centring mainly around the issue of risk to the donor (estimated at one donor death per 1600 nephrectomies) (1) and possible coercion of the donor. However, this practice exists (at the present time, approximately 15 per cent of all kidneys transplanted in North America stem from living donors) (2, 3) and is sanctioned by the international transplant organizations. In contrast, the international transplant community has roundly condemned the practice of living unrelated donation which involves payment of the donor (4, 5) . All older origin, adopted to protect against the commercialization of other organs, as in Italy, whereas other nations, such as Great Britain, passed the law in response to incidents of sale of kidneys for trans- plantation.
Yet the practice of paid, unrelated donation is flourishing in a number of developing countries, such as Brazil, Egypt and India where endemic poverty ensures vast numbers of willing donors and existing laws provide no guidelines for the practice (6, 7) . In a country such as India, where there is no cadaveric transplant programme and very little dialysis available (the most optimistic estimates cite 18,000 patients with access to dialysis per year, in contrast to the 80,000 new cases of renal failure per year) (8) , living donation is the only option for survival. For those with no suitable relatives, unrelated donation is the only possibility. This type of transplantation has taken many forms -from programmes in which the doctors match donor and recipient with good medical results, to much less professional scenarios with unscrupulous middlemen, 'organ brokers', haunting impoverished towns, with high donor and recipient mortality (9) . The reaction of the western medical establishment to reports of this practice was swift condemnation. However, within the Indian transplant community there exists no monolith of opinion. Some of the physicians see this practice as providing a service to both the recipient and the donor, and as the only alternative until a cadaveric programme can be established (10) . Others see the practice as unethical, unregulatable and a hindrance to the development of a cadaveric programme (11) . The Indian doctors are, however, unanimous in their condemnation of the western reaction, as being formulated in the vacuum of the reality of the situation in India.
At present, most decisions concerning the sale of organs both abroad and at home have been taken by the transplant community and the government. In light of the Indian practice and the strong western reaction against it we were interested in hearing the voice of the general public. We decided to undertake an attitude survey on the sale of kidneys for transplantation within and without the medical community. We chose to poll the general public, first-year medical students, non-transplant physicians and nurses, and transplant physicians and nurses to see if any marked differences in attitude exist among the groups. We used both a Canadian and an Indian medical-case scenario to determine whether the response was any different in a situation in which the sale of a kidney was the only option for survival, as in India, versus one in which long-term dialysis and the possibility of eventual cadaveric donation was available. By so doing, we sought to establish whether people's beliefs about the sale of organs are dependent on a given set of circumstances, or whether they are dictated by a set of universal ethical principles. Since (David) or India (Varun). The second question asked whether such a practice should be allowed, regardless of the present legal status. If the respondents answered 'no' they were finished with the survey. If they responded affirmatively other questions followed, 24 in the case of David, 22 in the case of Varun, some with subquestions, to determine which conditions were important in the respondent's decision. These factors ranged from details of the recipient's age, profession and ability to pay; the donor's health, nationality and reason for needing the money earned with the sale, to issues of regulation and funding. The questions were almost identical for the two questionnaires with the exception of two supplemental questions for David's case which dealt with aspects of his dialysis not applicable in Varun's case. All respondents were then asked to supply their age, profession and gender and to indicate whether they were professionally involved with transplantation or were personally acquainted with a renal transplant recipient. A space was provided at the end of the survey for additional comments.
A statistical analysis was performed using the SAS statistical package. A chi square test for statistical significance was done for each question. Twentyone of the surveys were omitted from analysis for reasons of incompleteness (if more than four questions were left unanswered), or in the case of one from the public sample because of the psychotic nature of the comments at the end of the survey.
Results
We received responses from 70 (47 per cent) of the public (Pu) of which seven were rejected, from 89 (89 per cent) of the first-year medical students (MS), from 117 (69 per cent) of the physicians and nurses (Med), of which 13 were rejected, and from 46 (74 per cent) of the transplant doctors, nurses and technicians (Tx), of which one was rejected. Given the length and the complexity of the subject matter of the survey, we considered the overall response rate to be reasonable. The response rate of the public, while lower than that of the medical students and healthcare professionals, was still high enough to provide an overall picture of attitudes. The biographical information (including personal knowledge of, or relationship to, a kidney donor or recipient) provided by the respondents did not indicate any obvious bias common to those who responded from the public. However, as with any survey, it is impossible to eliminate the possibility of response/non-response bias.
SHOULD DAVID AND VARUN BE ALLOWED TO BUY A KIDNEY?
The total percentage of responses sanctioning the purchase of a kidney was remarkably similar for Varun and David (see Table 1 ). Forty-nine per cent of all respondents to the Indian case would find the sale permissible, whereas in the Canadian case 40 per cent would. There was however, a marked difference between the groups on the issue. The public answered 'yes' at rates of 69 There was considerable unanimity between the groups as to which factors were important in their decision to allow the sale of a kidney for both cases (see Table 2 ). The following were considered important by over 70 per cent of all respondents: severity of the recipient's condition; uncertainty of receiving a kidney from a cadaver; impossibility of receiving dialysis for Varun and the side-effects of dialysis for David; health of the donor and the medical risk to the donor; who obtained consent and the circumstances under which it was obtained; the way in which the sale was arranged, of which a majority were in favour of the transplant hospital or a not-for-profit agency arranging the sale and not in favour of a for-profit organization doing so. There was less consensus as to whether the recipient, the doctors or the government should be able to initiate the sale. About half the respondents would allow the donor to initiate the sale in the Canadian context, but fewer than one third would want the Indian donor to be able to initiate the sale.
A large majority of the respondents thought it important that there be institutions regulating the practice. The overwhelming majority were There is no overwhelming mandate from our results, either from the public or even from the healthcare professionals, especially the transplant group, to indicate that the issue is resolved. Furthermore, in our own society these issues lie in the not-so-distant future. The numbers on the waiting lists are increasing, and the high costs of technology such as dialysis will force the issue into the political arena. There have already been many proposals by economists and lawyers for 'futures markets' for cadaveric donation (13, 14) to decrease the numbers of patients on waiting lists. Surely the sale of kidneys and other organs is not such a leap of logic from such proposals. The debate should be welcomed for many reasons. Our survey clearly shows that there is no clear consensus on this issue. Whatever reasons account for the differences in attitude between the healthcare profession and the public must be made known. If this practice is to be banned, then the reasoning behind the prohibition must be formulated and debated in the public arena. This debate will touch on some of our most culturally sensitive issues -such as those of the sanctity of the body versus the sanctity of life -as well as more pragmatic issues of resource allocation and individual rights. The sale of kidneys for transplantation is only one of many practices that challenge these issues.
